Track topics on Twitter Track topics that are important to you
The FDA approved the immunotherapy drug, a PD-L1 inhibitor, for patients with metastatic NSCLC who have progressed after platinum-based chemotherapy and targeted therapy, if appropriate.
Original Article: Tecentriq Approved for Metastatic Non-Small Cell Lung CancerNEXT ARTICLE
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...